MolNFT v1 · #54106 · protein
Human PATL1 C-terminal domain (loop variant)
2XES · Protein PAT1 homolog 1: “Human PATL1 C-terminal domain (loop variant)”. X-ray diffraction, 2 ligands (K, SCN), 3 pockets (best druggability 0.72). MolNFT v1 #54106 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 2XES
- Type
- protein
- Length
- 472 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Protein PAT1 homolog 1
- UniProt
- Q86TB9
- Ligands
- K, SCN
- Pockets
- 3 · best druggability 0.72
Structure
x-ray diffraction · 2 distinct chains · 73% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Protein PAT1 homolog 1 | protein | 234 | 74% helix, 0% strand | Q86TB9 |
| B | Protein PAT1 homolog 1 | protein | 238 | 72% helix, 1% strand | Q86TB9 |
Ligands and binding sites
- K · Potassium ion · metal · 2 copies · chains A, B
- SCN · Thiocyanate ion · ion · 4 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 456 | 0.72 | 0.82 | 37 | empty |
| 2 | 142 | 0.58 | 0.83 | 29 | SCN |
| 3 | 227 | 0.50 | 0.75 | 30 | empty |
Interfaces
1 interface between chains.
- A–B · 857 Ų buried · 4 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 16 modified (engineered).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q86TB9
- Elsewhere: RCSB PDB 2XES · PDBe 2XES · UniProt Q86TB9
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.